LIFE SCIENCES & Health

At the heart of Health Valley

The canton of Vaud is home to a very significant number of high-quality infrastructures as well as knowledge and expertise in the field of life sciences. Indeed, the region is often referred to as "Health Valley."

The University Hospital of the Canton of Vaud (CHUV) plays a central role in the sectors of medical care, research, and training. It develops ambitious projects such as "Neurotech,” a platform that is unique in Europe and which is dedicated to the evaluation of the impact of new technologies in the field of neurosciences. The department of oncology, led by Professor George Coukos, conducts renowned international work into cancer research, while Agora, a center devoted to cancer research, will be inaugurated in 2018 and will feature 300 researchers and doctors.

The region has positioned itself at the forefront of research in these domains, and also in the fields of neurosciences, immunology, nutrition, and cardiovascular diseases. Innovative disciplines such as bioinformatics, medical imaging, and robotic surgery are also developing rapidly.

The canton has almost 400 businesses and as many laboratories active in life sciences, and the ecosystem in Vaud is continually being enriched by the creation of start-ups. In 2016, new companies in Health Valley attracted 7.4% of global venture capital investment in the sector.

Around 60 companies from abroad, including Medtronic and Becton Dickinson, have chosen to develop their industrial activities and services in the region.

Find out more about Life Sciences in Vaud

Download the factsheet

«Thanks to its central location in “Health Valley,” Medtronic benefits from the expertise it needs during the entire lifecycle of its products: from industrialization to scale-up, manufacturing and commercialization. Medtronic’s training center for healthcare professionals, on the campus of our EMEA headquarters, is also ideally situated to contribute to the local life sciences ecosystem.»

Rob Ten Hoedt
Executive Vice President & President, EMEA, Medtronic

Our success stories

Parker Hannifin

For over a century, Parker Hannifin has contributed to technological advances that create a better world. With its Europe, Middle East & Africa (EMEA) headquarters in the Canton of Vaud, the US conglomerate offers solutions in a broad range of markets and industrial applications.

Merck

Merck develops advanced treatments in the canton of Vaud. Now, the German multinational plans to expand its production capacity in the region.

Incyte

Incyte Biosciences International Sàrl, headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with leading-edge medicines. It is working on new medicines to advance the treatment of various forms of acute and chronic leukemia, lung cancer and other difficult-to-treat cancers.

See all our success stories

News and events

10/28/2021

Tech Tour Alpine 2021

With 8 years of history, the Tech Tour Alpine Programme is focused on helping innovative technology companies in the Alpine region to exchange contacts, secure growth, and investment by working together with peers, experts and active investors in building lasting business co-operations.

Lausanne

Free tickets for PME & Startups

9/30/2021

Innovaud collaborates with Skolkovo, the "Russian Silicon Valley"

On September 22, Innovaud co-organized an event which enabled 4 startups from the Russian Innovation Center Skolkovo, active in digital health, to receive feedback from Swiss experts. This collaboration followed Innovaud's visit to Skolkovo in February 2021.

9/8/2021

23 Vaud startups in the TOP 100 2021

The TOP 100 Swiss startups were unveiled on 8 September in Schlieren (ZH). Some 23 of these young companies come from the canton of Vaud, and 10 of them are newcomers to the ranking this year. CREAL and AgroSustain enter the TOP 10. The canton of Vaud has confirmed its attractiveness to young, promising technology companies with the potential of becoming Vaud's next scale-ups that successfully make it to the stock market, such as SOPHiA GENETICS and Astrocast.

See all the news See all the events